FDA Adverse Event Malfunction Summary report: N

D-DIMER

MDR report key: 11737056 · Received April 28, 2021

Report

Report Number
1823260-2021-01269
Event Type
Malfunction
Date Received
April 28, 2021
Date of Event
April 1, 2021
Report Date
July 8, 2021
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GHH
PMA / PMN Number
K062203
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
EG
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

THE QC DATA SHOWS IMPRECISION. THE ALARM TRACE SHOWS CLOT ALARMS. FURTHER INFORMATION FROM THE CUSTOMER SIDE AND THE SAMPLE MATERIAL WERE REQUESTED BUT NOT PROVIDED. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED.

Additional Manufacturer Narrative · 0

DISCREPANT RESULTS FOR TWO MORE SAMPLES RAN ON AN UNKNOWN DATE ARE AS FOLLOWS. SAMPLE 1: THE INTEGRA 400 RESULT WAS 5.4 UG/ML. THE MANUAL METHOD RESULT WAS 0.4 UG/ML. SAMPLE 2: THE INTEGRA 400 RESULT WAS 3.7 UG/ML. THE MANUAL METHOD RESULT WAS 0.6 UG/ML.

Additional Manufacturer Narrative · 1

THIS INVESTIGATION IS ONGOING. THIS EVENT OCCURRED IN (B)(6). UNIQUE IDENTIFIER (UDI) #: (B)(4).

Description of Event or Problem · 1

THE INITIAL REPORTER RECEIVED A QUESTIONABLE D-DIMER GEN. 2 RESULT FOR ONE PATIENT WITH THE COBAS INTEGRA 400 PLUS SERIAL NUMBER (B)(4). THE INITIAL RESULT WAS 2.58 UG/ML. THIS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY. THE SAMPLE WAS TESTED IN ANOTHER LAB (METHOD UNKNOWN) WITH A RESULT OF 0.3 UG/ML. ON (B)(6) 2021, THE SAMPLE WAS REPEATED ON THE INTEGRA 400 WITH A RESULT OF 3.86 UG/ML. THE SAMPLE WAS ALSO TESTED IN MORE THAN ONE OTHER LABORATORY, AND ALL RESULTS WERE NORMAL (< 0.5 UG/ML).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
638101 D-DIMER FIBRIN SPLIT PRODUCTS GHH ROCHE DIAGNOSTICS NA 51964501

Patients

Seq Age Sex Outcome Treatment
1